Mer treffsikker fosterdiagnostikk
- 1.
Stortinget. Endringer i bioteknologiloven mv. https://www.stortinget.no/no/Saker-og-publikasjoner/Saker/Sak/?p=77395 Lest 8.9.2021.
- 2.
Flori E, Doray B, Gautier E et al. Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report. Hum Reprod 2004; 19: 723–4. [PubMed][CrossRef]
- 3.
Lo YM, Corbetta N, Chamberlain PF et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485–7. [PubMed][CrossRef]
- 4.
Lo YM, Zhang J, Leung TN et al. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999; 64: 218–24. [PubMed][CrossRef]
- 5.
Chiu RW, Chan KC, Gao Y et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 2008; 105: 20458–63. [PubMed][CrossRef]
- 6.
Stokowski R, Wang E, White K et al. Clinical performance of non-invasive prenatal testing (NIPT) using targeted cell-free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies. Prenat Diagn 2015; 35: 1243–6. [PubMed][CrossRef]
- 7.
Guseh SH. Noninvasive prenatal testing: from aneuploidy to single genes. Hum Genet 2020; 139: 1141–8. [PubMed][CrossRef]
- 8.
LOV-2020-06-19-78. Lov om endringer i bioteknologiloven mv. https://lovdata.no/dokument/LTI/lov/2020-06-19-78 Lest 8.9.2021.
- 9.
Helsedirektoratet. Fosterdiagnostikk. https://www.helsedirektoratet.no/tema/bioteknologi/fosterdiagnostikk Lest 8.9.2021.
- 10.
Sitras V, Ulriksen M, Benth JŠ et al. Gravide kvinners holdning til fosterdiagnostikk. Tidsskr Nor Legeforen 2020; 140. doi: 10.4045/tidsskr.20.0098. [PubMed][CrossRef]
- 11.
Gil MM, Accurti V, Santacruz B et al. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2017; 50: 302–14. [PubMed][CrossRef]
- 12.
Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011; 31: 7–15. [PubMed][CrossRef]
- 13.
Hartwig TS, Ambye L, Sørensen S et al. Discordant non-invasive prenatal testing (NIPT) - a systematic review. Prenat Diagn 2017; 37: 527–39. [PubMed][CrossRef]
- 14.
Fretts RC. Effects of advanced maternal age on pregnancy. UpToDate. https://www.uptodate.com/contents/effects-of-advanced-maternal-age-on-pregnancy Lest 8.9.2021.
Treffsikker fosterdiagnostikk gir nye etiske spørsmål
14.10.2021Ida Wiig Sørensen og kollegaer skriver fint om NIPT-basert trisomitesting (1) og forklarer spesielt godt hvordan testenes prediktive verdier avhenger av tilstandenes hyppighet. Kronikken tar utgangspunkt i det som er dagens praksis: screening for trisomi 13…